Approval · Notice of Compliance 25777 · 2021
OLMETEC: Notice of Compliance 25777
Issued April 30, 2021
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 25777
- Date
- April 30, 2021
- Company
- Organon Canada Inc.Kirkland, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Change in product ownership
Products in this notice
Medicinal ingredients
- OLMESARTAN MEDOXOMIL 5 MG per TAB
- OLMESARTAN MEDOXOMIL 20 MG per TAB
- OLMESARTAN MEDOXOMIL 40 MG per TAB